The Functional Properties and Physiological Roles of Signal-Transducing Adaptor Protein-2 in the Pathogenesis of Inflammatory and Immune Disorders.
T cell antigen receptor (TCR)
T cells
immune response
signal transduction
signal-transducing adaptor protein-2 (STAP-2)
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
30 Nov 2022
30 Nov 2022
Historique:
received:
05
11
2022
revised:
24
11
2022
accepted:
26
11
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Adaptor molecules play a crucial role in signal transduction in immune cells. Several adaptor molecules, such as the linker for the activation of T cells (LAT) and SH2 domain-containing leukocyte protein of 76 kDa (SLP-76), are essential for T cell development and activation following T cell receptor (TCR) aggregation, suggesting that adaptor molecules are good therapeutic targets for T cell-mediated immune disorders, such as autoimmune diseases and allergies. Signal-transducing adaptor protein (STAP)-2 is a member of the STAP family of adaptor proteins. STAP-2 functions as a scaffold for various intracellular proteins, including BRK, signal transducer, and activator of transcription (STAT)3, STAT5, and myeloid differentiation primary response protein (MyD88). In T cells, STAP-2 is involved in stromal cell-derived factor (SDF)-1α-induced migration, integrin-dependent cell adhesion, and Fas-mediated apoptosis. We previously reported the critical function of STAP-2 in TCR-mediated T cell activation and T cell-mediated autoimmune diseases. Here, we review how STAP-2 affects the pathogenesis of T cell-mediated inflammation and immune diseases in order to develop novel STAP-2-targeting therapeutic strategies.
Identifiants
pubmed: 36551835
pii: biomedicines10123079
doi: 10.3390/biomedicines10123079
pmc: PMC9776019
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 19H03364
Organisme : Japan Society for the Promotion of Science
ID : 21K08451
Références
J Immunol. 2012 Jun 15;188(12):6194-204
pubmed: 22611243
Int Immunol. 1999 Jun;11(6):943-50
pubmed: 10360968
Cancer Sci. 2011 Apr;102(4):756-61
pubmed: 21205088
Biochem Biophys Res Commun. 2021 Jun 4;556:185-191
pubmed: 33845308
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11976-81
pubmed: 10518561
Cold Spring Harb Perspect Biol. 2010 Jul;2(7):a002287
pubmed: 20519342
J Immunol. 2007 Mar 15;178(6):3786-96
pubmed: 17339477
J Immunol. 2007 Aug 15;179(4):2397-407
pubmed: 17675501
Nat Rev Immunol. 2010 Sep;10(9):645-56
pubmed: 20725108
Mol Cell Biol. 2003 Apr;23(7):2515-29
pubmed: 12640133
Biochem Biophys Res Commun. 2000 Feb 24;268(3):697-703
pubmed: 10679268
Sci STKE. 2000 Dec 19;2000(63):re1
pubmed: 11752630
J Biol Chem. 2005 Mar 4;280(9):8188-96
pubmed: 15611091
Signal Transduct Target Ther. 2021 Dec 13;6(1):412
pubmed: 34897277
Oncogene. 2020 Aug;39(34):5601-5615
pubmed: 32661325
J Clin Cell Immunol. 2012 Oct 27;2012(Suppl 12):5
pubmed: 23946894
Oncogene. 2000 Aug 31;19(37):4273-82
pubmed: 10980601
Annu Rev Immunol. 2003;21:335-76
pubmed: 12524386
Nat Immunol. 2005 Nov;6(11):1133-41
pubmed: 16200068
Proc Natl Acad Sci U S A. 1988 Nov;85(22):8613-7
pubmed: 3263650
Nat Rev Immunol. 2018 Aug;18(8):485-497
pubmed: 29789755
J Immunol. 2022 Jul 1;209(1):57-68
pubmed: 35725273
Biochem Biophys Res Commun. 2007 Jul 6;358(3):931-7
pubmed: 17512498
Biochem Biophys Res Commun. 2009 Jun 19;384(1):71-5
pubmed: 19393627
J Biol Chem. 2001 Nov 30;276(48):45175-83
pubmed: 11572860
J Biol Chem. 2003 Mar 28;278(13):11182-9
pubmed: 12540842
Sci Signal. 2011 Dec 06;4(202):ra85
pubmed: 22155789
Oncotarget. 2017 May 9;8(19):30766-30780
pubmed: 28430604
Nat Rev Immunol. 2011 Jan;11(1):47-55
pubmed: 21127503
J Immunol. 2002 Sep 15;169(6):2823-7
pubmed: 12218091
J Biol Chem. 1997 Oct 3;272(40):25401-8
pubmed: 9312162
Science. 1998 Jul 17;281(5375):413-6
pubmed: 9665884
Immunity. 1999 Mar;10(3):323-32
pubmed: 10204488
Biol Pharm Bull. 2021;44(7):895-901
pubmed: 34193686
Exp Mol Med. 2020 May;52(5):750-761
pubmed: 32439954
Biol Pharm Bull. 2008 Sep;31(9):1790-3
pubmed: 18758078
Cell. 2002 Sep 20;110(6):673-87
pubmed: 12297042
Cell. 1998 Jul 24;94(2):229-38
pubmed: 9695951
Biochem Biophys Res Commun. 2007 May 4;356(2):517-22
pubmed: 17368569
J Immunol. 2006 Jan 1;176(1):380-9
pubmed: 16365431
J Biol Chem. 2017 Nov 24;292(47):19392-19399
pubmed: 28986450
J Immunol. 2009 Dec 15;183(12):7966-74
pubmed: 19933863
Biochem Biophys Res Commun. 2017 Jun 17;488(1):81-87
pubmed: 28478037
Oncogene. 2001 Oct 1;20(44):6284-90
pubmed: 11607830
Blood. 2002 Mar 1;99(5):1866-9
pubmed: 11861309
Nat Immunol. 2018 Jul;19(7):733-741
pubmed: 29915297
Biochem Biophys Res Commun. 2001 Nov 30;289(2):414-20
pubmed: 11716489
Oncogene. 2012 Oct 4;31(40):4384-96
pubmed: 22231445